FDA statement on relationship between bisphosphonate use and atypical subtrochanteric and femoral shaft fractures: a considered opinion

AJR Am J Roentgenol. 2010 Sep;195(3):563-6. doi: 10.2214/AJR.10.4906.
No abstract available

MeSH terms

  • Diphosphonates / adverse effects*
  • Femoral Fractures / chemically induced*
  • Femoral Fractures / diagnosis
  • Humans
  • Risk Factors
  • United States
  • United States Food and Drug Administration*

Substances

  • Diphosphonates